HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,795 shares of the company’s stock after selling 795 shares during the period. State of Alaska Department of Revenue’s holdings in HCA Healthcare were worth $6,241,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare in the third quarter valued at approximately $39,000. Canoe Financial LP acquired a new position in shares of HCA Healthcare during the third quarter worth $41,000. Capital Performance Advisors LLP purchased a new stake in HCA Healthcare during the 3rd quarter worth about $41,000. Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth about $44,000. Finally, Pinnacle Bancorp Inc. increased its stake in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on HCA shares. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $385.67.

Insider Activity

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Trading Down 0.8 %

Shares of HCA Healthcare stock opened at $321.95 on Friday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $81.55 billion, a PE ratio of 14.65, a price-to-earnings-growth ratio of 1.13 and a beta of 1.64. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a 50-day moving average of $313.85 and a two-hundred day moving average of $353.37.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the company posted $5.90 earnings per share. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.89 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.89%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is 12.02%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.